Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-005203
Filing Date
2015-09-22
Accepted
2015-09-22 16:58:53
Documents
1
Period of Report
2015-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6278
  Complete submission text file 0000899243-15-005203.txt   7993
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCICLONE PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404-2125
Business Address
Titus Gary (Reporting) CIK: 0001298900 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 151119789